Evidence map›Paper›PMID 26149722›Full record

Trial reportBMC medicine2015

A combination SMS and transportation reimbursement intervention to improve HIV care following abnormal CD4 test results in rural Uganda: a prospective observational cohort study.

Mark J Siedner, Data Santorino, Alexander J Lankowski, Michael Kanyesigye, Mwebesa B Bwana, Jessica E Haberer, David R Bangsberg

Registry-linked trialAbstract readClinical TrialPragmatic Clinical TrialRandomized Controlled Trial
In one paragraph

Trial report in BMC medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01579214 (Cell Phone Messaging to Improve Communication of Critical Laboratory Results to Patients in Rural Uganda), which is not on this map. Cited by 39 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed, 5 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01579214 nacompletednot on this map

Cell Phone Messaging to Improve Communication of Critical Laboratory Results to Patients in Rural Uganda

TypeinterventionalSponsorMassachusetts General HospitalRan2012 to 2015Enrolled183ConditionsHIV, TuberculosisArmsCellular Phone Text Messages
3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 5 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Trial
  8. Trial
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. 'We have goals but [it is difficult]'. Barriers to antiretroviral therapy adherence among women using alcohol and other drugs living with HIV in South Africa.Health expectations : an international journal of public participation in health care and health policy · 2022
    Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Mark J SiednerDivision of Infectious Diseases, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, 100 Cambridge Street, 15th Floor, Boston, MA, 02114, USA. msiedner@mgh.harvard.edu.
Data SantorinoMbarara University of Science and Technology, Mbarara, Uganda. boymukedata@gmail.com.
Alexander J LankowskiDepartment of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, 02114, USA. alexlankowski@gmail.com.
Michael KanyesigyeMbarara University of Science and Technology, Mbarara, Uganda. mkanyesigye2010@gmail.com.
Mwebesa B BwanaMbarara University of Science and Technology, Mbarara, Uganda. mwebesa_bwana@yahoo.com.
Jessica E HabererDepartment of Medicine, Massachusetts General Hospital, Harvard Medical School, and Harvard School of Public Health, Boston, MA, 02114, USA. jhaberer@mgh.harvard.edu.
David R BangsbergDivision of Infectious Diseases, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, 100 Cambridge Street, 15th Floor, Boston, MA, 02114, USA. dbangsberg@mgh.harvard.edu.

Funding

Fogarty International Clinical Research Scholars Support Center @ Vanderbilt-AAMCR24TW007988 · FIC · VANDERBILT UNIVERSITY · PI VERMUND, STEN H. · 2007 to 2011
$27.6M
PROGRAM FOR AIDS CLINICAL RESEARCH TRAINING (PACRT)T32AI007433 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI MARK J SIEDNER · 1992 to 2026
$11.4M
Behavioral Aspects of Low-cost Medical Devices to Improve HIV CareK23MH099916 · NIMH · MASSACHUSETTS GENERAL HOSPITAL · PI SIEDNER, MARK J · 2013 to 2017
$917k
FIC NIH HHS R24 TW007988NIAID NIH HHS T32 AI007433NIMH NIH HHS K23 MH099916
6 · The paper itself

Abstract

backgroundUp to 50 % of HIV-infected persons in sub-Saharan Africa are lost from care between HIV diagnosis and antiretroviral therapy (ART) initiation. Structural barriers, including cost of transportation to clinic and poor communication systems, are major contributors.

methodsWe conducted a prospective, pragmatic, before-and-after clinical trial to evaluate a combination mobile health and transportation reimbursement intervention to improve care at a publicly operated HIV clinic in Uganda. Patients undergoing CD4 count testing were enrolled, and clinicians selected a result threshold that would prompt early return for ART initiation or further care. Participants enrolled in the pre-intervention period (January - August 2012) served as a control group. Participants in the intervention period (September 2012 - November 2013) were randomized to receive daily short message service (SMS) messages for up to seven days in one of three formats: 1) messages reporting an abnormal result directly, 2) personal identification number-protected messages reporting an abnormal result, or 3) messages reading "ABCDEFG" to confidentially convey an abnormal result. Participants returning within seven days of their first message received transportation reimbursements (about $6USD). Our primary outcomes of interest were time to return to clinic and time to ART initiation.

resultsThere were 45 participants in the pre-intervention period and 138 participants in the intervention period (46, 49, and 43 in the direct, PIN, and coded groups, respectively) with low CD4 count results. Median time to clinic return was 33 days (IQR 11-49) in the pre-intervention period and 6 days (IQR 3-16) in the intervention period (P < 0.001); and median time to ART initiation was 47 days (IQR 11-75) versus 12 days (IQR 5-19), (P < 0.001). In multivariable models, participants in the intervention period had earlier return to clinic (AHR 2.32, 95 %CI 1.53 to 3.51) and earlier time to ART initiation (AHR 2.27, 95 %CI 1.38 to 3.72). All three randomized message formats improved time to return to clinic and time to ART initiation (P < 0.01 for all comparisons versus the pre-intervention period).

conclusionsA combination of an SMS laboratory result communication system and transportation reimbursements significantly decreased time to clinic return and time to ART initiation after abnormal CD4 test results. TRIAL REGISTRATIONS: Clinicaltrials.gov NCT01579214 , approved 13 April 2012.

Indexed as

AdultAmbulatory Care FacilitiesAnti-HIV AgentsCohort StudiesFemaleHealth Services AccessibilityHIV InfectionsHumansMaleMiddle AgedPatient ComplianceProspective StudiesReimbursement MechanismsRural PopulationText MessagingTransportationAnti-HIV Agents

Identifiers

PMID26149722
PMCPMC4494725

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.